Arcutis Biotherapeutics has appointed Christopher Peetz to its Board of Directors effective July 15, 2026. Peetz is co-founder and chief executive officer of Mirum Pharmaceuticals, a global organization focused on rare diseases, and brings extensive experience in guiding biopharmaceutical companies through expansion, product development, and strategic acquisitions. Arcutis president and CEO Frank Watanabe stated that Peetz's expertise will strengthen the board as the company executes its strategy to grow the ZORYVE franchise, expand into new indications, and build its pipeline. Board chairman Keith R. Leonard added that Peetz's proven leadership in building and scaling innovative organizations will be invaluable for Arcutis's next phase of growth. Peetz expressed honor in joining the board and looks forward to supporting the company's continued growth and success.
Arcutis Biotherapeutics IncAppointment of experienced biopharma executive to board strengthens governance and strategic execution for ZORYVE franchise growth.
Mirum Pharmaceuticals Inc